Status:
COMPLETED
Screening Women for Functional Hypothalamic Amenorrhea (FHA)
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
University College, London
Conditions:
Amenorrhea Secondary
Eligibility:
FEMALE
18-58 years
Brief Summary
What do the investigators know already? Many women suffer loss of periods (amenorrhoea). One of the most common causes of period loss is called 'functional hypothalamic amenorrhea' (FHA). FHA is diffi...
Detailed Description
A questionnaire was developed to be used by women with period loss to facilitate the diagnosis of women with FHA. The development of the questionnaire was based on systematic literature review and com...
Eligibility Criteria
Inclusion
- Any woman 18-58 years of age
- Secondary amenorrhea defined by either menstrual cycle interval persistently exceeding 45 days and/or those with period loss for 3 months or more
Exclusion
- Women who never had periods (primary amenorrhea).
Key Trial Info
Start Date :
February 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 2 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05410886
Start Date
February 11 2021
End Date
February 2 2024
Last Update
April 29 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospital NHS Trust
London, United Kingdom, NW1 2BU
2
Imperial College Healthcare NHS Trust
London, United Kingdom, W12 0HS